Despite a recent study in the Journal of the American Medical Association (3/9/05) suggesting that computerized physician order entry (CPOE) systems may not live up to their promise of reducing medication errors, the Illinois Hospital Association has decided to launch a pilot CPOE program in 26 hospitals in the state.
Despite a recent study in the Journal of the American Medical Association (3/9/05) suggesting that computerized physician order entry (CPOE) systems may not live up to their promise of reducing medication errors, the Illinois Hospital Association has decided to launch a pilot CPOE program in 26 hospitals in the state. The pilot program hopes to capitalize on the success of a computerized system implemented at St. Francis Hospital in Peoria, Ill., which reduced adverse drug reactions "from 4 per 1,000 doses of medication 5 years ago to 1.4 today," according to the Chicago Tribune (4/11/05).
The researchers of the JAMA study looked at a CPOE system used in an urban teaching hospital and found that the system contributed to the occurrence of 22 types of medication errors. (For more about the JAMA study, see the May issue of Contemporary Ob/Gyn) Proponents of automated health-care systems that help improve drug safety downplay the study's findings, noting that the researchers studied an older CPOE system. The study also did not examine whether the CPOE system actually reduced the volume of errors-by comparing the error rate before and after the system was introduced-according to David Bates, medical director of clinical quality and analysis in information systems at Partners HealthCare Systems in Boston (Modern Healthcare, 3/14/05).
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More